Costarting sitagliptin with metformin is associated with a lower likelihood of disease progression in newly treated people with type 2 diabetes: a cohort study. [electronic resource]
Producer: 20211101Description: 1715-1722 p. digitalISSN:- 1464-5491
- Adult
- Alberta
- Cohort Studies
- Diabetes Mellitus, Type 2 -- drug therapy
- Disease Progression
- Drug Therapy, Combination
- Female
- Glycated Hemoglobin -- metabolism
- Humans
- Hypoglycemic Agents -- therapeutic use
- Logistic Models
- Male
- Metformin -- therapeutic use
- Middle Aged
- Retrospective Studies
- Sitagliptin Phosphate -- therapeutic use
No physical items for this record
Publication Type: Journal Article; Research Support, Non-U.S. Gov't
There are no comments on this title.
Log in to your account to post a comment.